Loading company…
Riskpilot
← Back to search
Sign in
Get full access
CSK INVEST AS
AS
Active
Org 989159925
Høivold Brygge 187, 4631 Kristiansand S
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2006
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
+4% vs 2023
Equity ratio
68.9%
Financial strength
Net profit 2024
NOK -34K
+4% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -34K
+4%
Net profit
NOK -34K
+4%
Total assets
NOK 8,7M
-10%
Equity
NOK 6M
-5%
Employees
0
—
Company information
Legal name
CSK INVEST AS
Org number
989159925
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8. februar 2006
Share capital
NOK 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Eie samt kjøpe og selge aksjer i andre selskaper samt alt hva dermed står i naturlig sammenheng.
Contact
Address
Høivold Brygge 187, 4631 Kristiansand S
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Kristiansand
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
50
0
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−16
33
−19
−35
−34
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−16
33
−19
−35
−34
Net financials
0
0
0
0
0
Profit before tax
−16
33
−19
−35
−34
Tax
−0
−0
−0
−0
−0
Net profit
−16
33
−19
−35
−34
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
479
835
3 796
9 673
8 670
Equity
420
453
433
6 310
5 976
Long-term debt
0
0
0
0
0
Short-term debt
59
382
3 363
3 363
2 693
Total debt
59
382
3 363
3 363
2 693
Financial ratios
5-year trend
EBITDA margin
-3370000.0%
This company
15.8%
Market median
-21329214% vs market
2020
2024
Equity ratio
68.9%
This company
38.2%
Market median
+80% vs market
2020
2024
Return on equity
-0.6%
This company
18.4%
Market median
-103% vs market
2020
2024
Net profit margin
-3370000.0%
This company
8.1%
Market median
-41605038% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
RS
Ragnhild Stene Gabrielsen Kolstad
Deputy Member
Deputy Member
2019
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
CS
Cato Stene Kolstad
Chairman
2019
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
CSK INVEST AS
(this company)
CSK INVEST AS
Aliva As
SIALO AS
ASALIVATOR AS
Meditek Medisinsk Utstyr As
Board network connections
Board members of CSK INVEST AS also hold positions in
0
other companies.
Person
Role here
Other companies
Ragnhild Stene Gabrielsen Kolstad
Deputy Member
0 companies
Cato Stene Kolstad
Chairman
0 companies